These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16865304)

  • 1. Autoperipheral blood mononuclear cell transplantation improved giant ulcers due to chronic arteriosclerosis obliterans.
    Sugihara S; Yamamoto Y; Matsubara K; Ishida K; Matsuura T; Ando F; Igawa G; Narazaki G; Miake J; Tajima F; Nishio R; Nakayama B; Igawa O; Shigemasa C; Hisatome I
    Heart Vessels; 2006 Jul; 21(4):258-62. PubMed ID: 16865304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans.
    Huang PP; Yang XF; Li SZ; Wen JC; Zhang Y; Han ZC
    Thromb Haemost; 2007 Dec; 98(6):1335-42. PubMed ID: 18064333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic angiogenesis by autologous transplantation of bone-marrow cells in a patient with progressive limb ischemia due to arteriosclerosis obliterans: a case report].
    Hasebe H; Osada M; Kodama Y; Fujioka D; Sano K; Nakamura T; Mitsumori T; Nakamura K; Kitta Y; Ichiki Y; Obata J; Kawabata K; Yanagi M; Sano S; Takano H; Umetani K; Kugiyama K
    J Cardiol; 2004 Apr; 43(4):179-83. PubMed ID: 15125382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and predictors of patients with critical limb ischemia who responded to autologous mononuclear cell transplantation for therapeutic angiogenesis.
    Aoyama N; Nishinari M; Ohtani S; Kanai A; Noda C; Hirata M; Miyamoto A; Watanabe M; Minamino T; Izumi T; Ako J
    Heart Vessels; 2017 Sep; 32(9):1099-1108. PubMed ID: 28357515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
    Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR
    J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A FOLLOW-UP STUDY ON AUTOLOGOUS BONE MARROW MONONUCLEAR CELLS TRANSPLANTATION FOR CRITICAL LOWER ARTERIOSCLEROSIS OBLITERANS IN DIABETIC PATIENTS].
    Dou Y; Zhao J; Zhang L; Wang X; Yuan H; Yuan C
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2015 Jul; 29(7):893-8. PubMed ID: 26540987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans.
    Durdu S; Akar AR; Arat M; Sancak T; Eren NT; Ozyurda U
    J Vasc Surg; 2006 Oct; 44(4):732-9. PubMed ID: 16926085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation.
    Kawamura A; Horie T; Tsuda I; Ikeda A; Egawa H; Imamura E; Iida J; Sakata H; Tamaki T; Kukita K; Meguro J; Yonekawa M; Kasai M
    Ther Apher Dial; 2005 Feb; 9(1):59-63. PubMed ID: 15828908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life improvement and long-term effects of peripheral blood mononuclear cell transplantation for severe arteriosclerosis obliterans in diabetic patients on dialysis.
    Hoshino J; Ubara Y; Hara S; Sogawa Y; Suwabe T; Higa Y; Nakanishi S; Sawa N; Katori H; Takemoto F; Fujimoto Y; Ohta E; Ohara K; Takaichi K
    Circ J; 2007 Aug; 71(8):1193-8. PubMed ID: 17652880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limb rescue: a new autologous-peripheral blood mononuclear cells technology in critical limb ischemia and chronic ulcers.
    De Angelis B; Gentile P; Orlandi F; Bocchini I; Di Pasquali C; Agovino A; Gizzi C; Patrizi F; Scioli MG; Orlandi A; Cervelli V
    Tissue Eng Part C Methods; 2015 May; 21(5):423-35. PubMed ID: 25341088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.
    Tateishi-Yuyama E; Matsubara H; Murohara T; Ikeda U; Shintani S; Masaki H; Amano K; Kishimoto Y; Yoshimoto K; Akashi H; Shimada K; Iwasaka T; Imaizumi T;
    Lancet; 2002 Aug; 360(9331):427-35. PubMed ID: 12241713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of autologous bone marrow mononuclear cells in six patients with advanced chronic critical limb ischemia as a result of diabetes: our experience.
    Subrammaniyan R; Amalorpavanathan J; Shankar R; Rajkumar M; Baskar S; Manjunath SR; Senthilkumar R; Murugan P; Srinivasan VR; Abraham S
    Cytotherapy; 2011 Sep; 13(8):993-9. PubMed ID: 21671823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans.
    Miyamoto K; Nishigami K; Nagaya N; Akutsu K; Chiku M; Kamei M; Soma T; Miyata S; Higashi M; Tanaka R; Nakatani T; Nonogi H; Takeshita S
    Circulation; 2006 Dec; 114(24):2679-84. PubMed ID: 17145986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters.
    Malyar NM; Radtke S; Malyar K; Arjumand J; Horn PA; Kröger K; Freisinger E; Reinecke H; Giebel B; Brock FE
    Cytotherapy; 2014 Sep; 16(9):1270-9. PubMed ID: 24972744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation.
    Nizankowski R; Petriczek T; Skotnicki A; Szczeklik A
    Kardiol Pol; 2005 Oct; 63(4):351-60; discussion 361. PubMed ID: 16273471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment.
    Dubsky M; Jirkovska A; Bem R; Fejfarova V; Pagacova L; Sixta B; Varga M; Langkramer S; Sykova E; Jude EB
    Diabetes Metab Res Rev; 2013 Jul; 29(5):369-76. PubMed ID: 23390092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous transplantation of bone marrow mononuclear cells for limb ischemia in a caucasian population with atherosclerosis obliterans.
    De Vriese AS; Billiet J; Van Droogenbroeck J; Ghekiere J; De Letter JA
    J Intern Med; 2008 Apr; 263(4):395-403. PubMed ID: 18221334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year results.
    Guo J; Guo L; Cui S; Tong Z; Dardik A; Gu Y
    Stem Cell Res Ther; 2018 Feb; 9(1):43. PubMed ID: 29471870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.
    Matoba S; Tatsumi T; Murohara T; Imaizumi T; Katsuda Y; Ito M; Saito Y; Uemura S; Suzuki H; Fukumoto S; Yamamoto Y; Onodera R; Teramukai S; Fukushima M; Matsubara H;
    Am Heart J; 2008 Nov; 156(5):1010-8. PubMed ID: 19061721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.